Guidelines Contributors

Andrew Bugbee, DVM, DACVIM
Department of Small Animal Medicine and Surgery, University of Georgia, Athens, Georgia

Renee Rucinsky, DVM, DABVP (Feline Practice)
Mid Atlantic Cat Hospital, Mid Atlantic Feline Thyroid Center, Queenstown, Maryland

Sarah Cazabon, DVM
Boston Veterinary Clinic, Boston, Massachusetts

Heather Kvitko-White, DVM, DACVIM
KW Veterinary Consulting, LLC, Kansas City, Missouri

Patty Lathan, VMD, MS, DACVIM (Small Animal Internal Medicine)
Mississippi State University, Mississippi State, Mississippi

Amy Nichelason, DVM, DABVP (Canine and Feline)
School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin

Liza Rudolph, BAS, RVT, VTS (Canine and Feline)(Small Animal Internal Medicine)
Rowan College of South Jersey, Sewell, New Jersey


Contributing Reviewers

Audrey Cook, BVM&S, FRCVS, DACVIM-SAIM, DECVIM-CA, DABVP (Feline)
Texas A&M University Department of Small Animal Clinical Sciences

Daniel Langlois, DVM, DACVIM
Michigan State University College of Veterinary Medicine


Correspondence: [email protected]

A. Bugbee and R. Rucinsky are the cochairs of the AAHA Selected Endocrinopathies of Dogs and Cats Guidelines Task Force.

These guidelines were prepared by a task force of experts convened by the American Animal Hospital Association. This document is intended as a guideline only, not an AAHA standard of care. These guidelines and recommendations should not be construed as dictating an exclusive protocol, course of treatment, or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to each individual practice setting. Evidence-guided support for specific recommendations has been cited whenever possible and appropriate. Other recommendations are based on practical clinical experience and a consensus of expert opinion. Further research is needed to document some of these recommendations. Drug approvals and labeling are current at the time of writing but may change over time. Because each case is different, veterinarians must base their decisions on the best available scientific evidence in conjunction with their own knowledge and experience.


The 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines are generously supported by Boehringer Ingelheim Animal Health, IDEXX, Merck, Zoetis, and Zomedica.

 
Boehringer Ingelheim
IDEXX
merck.png
Zoetis
Zoemedica